A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4+ T-cell response
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4+ T-cell response
Authors
Keywords
-
Journal
Nanomedicine
Volume 9, Issue 17, Pages 2625-2638
Publisher
Future Medicine Ltd
Online
2014-12-22
DOI
10.2217/nnm.14.197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physicochemical and functional characterization of vaccine antigens and adjuvants
- (2014) Antu K Dey et al. Expert Review of Vaccines
- Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities
- (2014) C. A. Cox et al. JOURNAL OF IMMUNOLOGY
- A Simple Mycobacterial Monomycolated Glycerol Lipid Has Potent Immunostimulatory Activity
- (2014) C. S. Andersen et al. JOURNAL OF IMMUNOLOGY
- CD4+ T Cell Subset Differentiation and Avidity Setpoint Are Dictated by the Interplay of Cytokine and Antigen Mediated Signals
- (2014) Erin K. Shiner et al. PLoS One
- Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant
- (2014) Karen Smith Korsholm et al. VACCINE
- Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
- (2014) Radha Gopal et al. PLoS Pathogens
- The Immune Response in Tuberculosis
- (2013) Anne O'Garra et al. Annual Review of Immunology
- Differential Involvement of Th1 and Th17 in Pathogenic Autoimmune Processes Triggered by Different TLR Ligands
- (2013) G. Shi et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Pathogenicity of IFN- -Producing Th17 Cells Is Independent of T-bet
- (2013) R. Duhen et al. JOURNAL OF IMMUNOLOGY
- Broadening of the T-Cell Repertoire to HIV-1 Gag p24 by Vaccination of HLA-A2/DR Transgenic Mice with Overlapping Peptides in the CAF05 Adjuvant
- (2013) Karen S. Korsholm et al. PLoS One
- High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway
- (2013) Claudia Volpi et al. Nature Communications
- The supramolecular structure is decisive for the immunostimulatory properties of synthetic analogues of a mycobacterial lipid in vitro
- (2013) Birte Martin-Bertelsen et al. RSC Advances
- Immunogenicity of protein aggregates—Concerns and realities
- (2012) Wei Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis
- (2012) Vahid Heravi Shargh et al. PARASITOLOGY RESEARCH
- CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice
- (2011) Jon Hansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
- (2011) F. Aranda et al. CANCER RESEARCH
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo
- (2010) Pernille Nordly et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Chlamydia muridarum T-Cell Antigens Formulated with the Adjuvant DDA/TDB Induce Immunity against Infection That Correlates with a High Frequency of Gamma Interferon (IFN- )/Tumor Necrosis Factor Alpha and IFN- /Interleukin-17 Double-Positive CD4+ T Cells
- (2010) H. Yu et al. INFECTION AND IMMUNITY
- Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice
- (2010) Qing Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method
- (2010) Pernille Nordly et al. JOURNAL OF CONTROLLED RELEASE
- Human Th17 Cells Comprise Heterogeneous Subsets Including IFN- -Producing Cells with Distinct Properties from the Th1 Lineage
- (2010) K. Boniface et al. JOURNAL OF IMMUNOLOGY
- Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo
- (2010) Pernille Nordly et al. PHARMACEUTICAL RESEARCH
- TLR Signals Promote IL-6/IL-17-Dependent Transplant Rejection
- (2009) Luqiu Chen et al. JOURNAL OF IMMUNOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More